Skip to main content

Advertisement

Log in

Tumor growth, invasion, and angiogenesis in malignant gliomas

  • Clinial Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Louis DN, Holland EC, Cairncross JG, 2001 Glioma classification, a molecular reappraisal Am J Pathol 159: 779–786

    PubMed  CAS  Google Scholar 

  2. Phuphanich S, Brat DJ, Olson JJ, 2004 Delivery systems and molecular targets of mechanism-based therapies for GBM Expert Rev Neurother 4: 649–663

    Article  PubMed  CAS  Google Scholar 

  3. Groves MD, Puduvalli VK, Hess KR, et al, 2002 Phase II trial of temozolomide plus the matrix metalloprotease inhibitor, marimastat, in recurrent and progressive glioblastoma multiforme J Clin Oncol 20: 1383–1388

    Article  PubMed  CAS  Google Scholar 

  4. Levin V, Phuphanich S, Glantz MJ, et al, 2002 Randomized phase II study of temozolomide (TMZ) with and without the matrix metalloprotease (MMP) inhibitor prinomastat in patients (pts) with glioblastoma multiforme (GBM) following best surgery and radiation therapy Proceed ASCO 21: 26a

    Google Scholar 

  5. Fine HA, Figg WD, Jaeckle K, et al, 2000 Phase II trial of the antiangiogenic agent thalidomide in patients with recurrence high-grade gliomas J Clin Oncol 18: 708–715

    PubMed  CAS  Google Scholar 

  6. Marx GM, Pavlakis N, McCowatt S, et al, 2001 Phase II study of thalidomide in the treatment of recurrent glioblastoma multiforme J Neurooncol 54: 31–38

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Eric T. Wong.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Wong, E.T. Tumor growth, invasion, and angiogenesis in malignant gliomas. J Neurooncol 77, 295–296 (2006). https://doi.org/10.1007/s11060-005-9042-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-005-9042-8

Keywords

Navigation